Little is known about the role of neurotrophic growth factors in bone metabolism. This study investigated the short-term effects of glial cell line-derived neurotrophic factor (GDNF) on calvarial-derived MC3T3-E1 osteoblasts. MC3T3-E1 expressed GDNF as well as its canonical receptors, GFR1 and RET. Addition of recombinant GDNF to cultures in serum-containing medium modestly inhibited cell growth at high concentrations; however, under serum-free culture conditions GDNF dose-dependently increased cell proliferation. GDNF effects on cell growth were inversely correlated with its effect on alkaline phosphatase (ALP) activity showing a significant dose-dependent inhibition of relative ALP activity with increasing concentrations of GDNF in serumfree culture medium. Live/dead and lactate dehydrogenase assays demonstrated GDNF did not significantly affect cell death or survival under serum-containing and serum-free conditions. The effect of GDNF on cell growth was abolished in the presence of inhibitors to GFR1 and RET indicating that GDNF stimulated calvarial osteoblasts via 221 its canonical receptors. Finally, this study found that GDNF synergistically increased tumor necrosis factor-α (TNF-α)-stimulated MC3T3-E1 cell growth suggesting that GDNF interacted with TNF-α-induced signaling in osteoblastic cells. In conclusion, this study provides evidence for a direct, receptor-mediated effect of GDNF on osteoblasts highlighting a novel role for GDNF in bone physiology.
along with GDNF in bone marrow stromal cells, RET proved to be absent in these cells (12) (13) . However, GDNF/GFR1 complexes cleaved from the stromal cells were shown to elicit functional signaling through RET expressed on hematopoietic and leukemic cells suggesting a signaling pathway involving cell-cell interactions within the bone marrow environment (13) (14) . In this study we addressed the question whether GDNF may be involved in bone metabolism. In particular, this study focused on the short term effects of GDNF on the proliferation and survival of osteoblastic cells using a non-transformed calvarial-derived cell line as model system for osteoblasts. In addition, the research investigated a possible interaction between GDNF and the multifunctional, pro-inflammatory cytokine, tumor necrosis factor-α (TNF-α).
Materials and methods

Cell cultures
The MC3T3-E1 cell line is a non-transformed, clonal osteoblast-like cell line established from mouse calvaria and has extensively been used as a physiologically relevant in vitro model for calvarial osteoblasts, osteogenic differentiation and bone formation (15) . MC3T3-E1 were acquired from the European Collection of Cell Cultures (ECACC) and were cultured in αMEM containing 10% Fetal Bovine Serum (FBS), 1% penicillin/streptomycin, 200 mM glutamine and 2.5 μg/ ml Amphotericin B (Sigma Aldrich, UK) in a humidified 5% CO 2 incubator at 37 o C. Subconfluent cell cultures were trypsinised using Trypsin/EDTA (Gibco, UK) and plated into 96-multiwell plates in MEM/10% FBS at 5,000 cells/well. After 24 hours, the cultures were replenished with either serum (10% FBS) or serum-free MEM supplemented with 0.1% bovine serum albumin (BSA). Recombinant human GDNF (rhGDNF, provided by Amgen, Thousand Oaks, USA) or TNF-α (PeproTech, UK) was added to the cultures for a further two days. For the receptor inhibitor experiments, cultures were treated for 1 hour with different concentrations of phosphoinositide phopsholipase C (PI-PLC; Sigma) which blocks signalling via GFRα1 (16), or RPI-1 (Merck/Calbiochem), a specific RET receptor tyrosine kinase inhibitor (17), followed by further culture with the respective inhibitors in media with or without GDNF.
Cell number and viability assays
The WST1 assay (Roche Applied Biosciences) was used to assess the number of viable cells (18); the absorbance of the reduced compound was measured at a wavelength of 450 with a reference filter at 630nm using a Biotek plate reader. The -live/dead‖ assay used 4µM acridine orange to stain nuclei of live cells and 4µM ethidium bromide to label nuclei of dead cells. The number of live and dead cells per microscopic field was counted under a Nikon Eclipse fluorescent microscope using 480 and 520nm filters, respectively. The level of cell death in the cultures was determined biochemically using a lactate dehydrogenase (LDH) cytotoxicity assay (Roche, UK). Cell culture supernatants were analysed after a 2-days' culture for the presence of LDH. Absorbance was determined at 490/630nm using the Biotek plate reader.
BrdU cell proliferation assay
Cell proliferation was assessed using a 5-bromo-2-deoxy-uridine (BrdU) labeling and detection kit (Roche Applied Sciences). In brief, cells were labeled with 10 μM BrdU for the final hour of the 48 hours' culture followed by fixation and immunostaining for BrdU incorporation using a specific anti-BrdU antibody. Cells were counterstained with hematoxylin and the total number of labeled and non-labeled nuclei were counted in 50 independent microscope fields.
Biochemical alkaline phosphate (AlP) assay
Cells were lysed in 0.1% Triton X-100 and incubated for 10 min in 1 M diethanolamine buffer (pH 9.8) containing 1mg/ml p-nitrophenyl phosphate (pNPP) at 37° C.
Production of PNP (p-nitrophenol) was quantified spectrophotometrically at an absorbance of 405 nm using an automatic plate reader.
Semi-quantitative RT-PCR (sqRT-PCR) analysis
Cells were lysed in RLT buffer containing β-mercaptoethanol followed by RNA isolation using the RNeasy minikit (Qiagen, UK). Subsequently, 1μg of DNase-digested total RNA was used for oligo(dT) (Ambion, UK) reverse transcription to generate single-stranded cDNA using the Omniscript kit (Qiagen, UK). Centrifugal filters (Microcon) were used to purify and concentrate resultant cDNA. Both RNA and cDNA concentrations were determined from absorbance values at a wavelength of 260 nm using a BioPhotometer (Eppendorf, UK). sqRT-PCR assays were performed using the RedTaq PCR system (Sigma, UK) and the Mastercycler gradient thermal cycler (Eppendorf, UK). Primers were designed from NCBI mRNA sequences using Primer-3 design software (Table 1 ).
Immunocytochemistry
MC3T3-E1 were seeded onto multispot microscope slides and incubated for 24h at 37 0 C in a humidified 5% CO 2 incubator (15,000 cells/well). The adherent cells were fixed with ice-cold acetone for 5 min followed by rinsing in phosphate-buffered saline (PBS) containing 1% BSA. Following incubation in 3% H 2 O 2 for 30 min (to block endogenous peroxidase), the slides were washed in PBS and incubated in 20% normal goat serum followed by incubation with 2 µg/ml primary polygonal rabbit antibody against GFRα1 datasheets). To demonstrate that the immunocytochemical staining was specific for the primary antibody, the primary antibody was substituted with 20% normal rabbit serum.
The slides were rinsed in PBS/1% BSA and labeled and stained with biotinstreptavidin-HRP using a Biogenex detection kit (LP000-UL). The slides were counterstained with haematoxylin before examination under a Zeiss microscope.
Data and statistical analysis
Data obtained from the WST-1, LDH and ALP assays were corrected for background values and expressed as percentage of controls. Data were analysed using ANOVA with
Tukey's posthoc test.
Results
Expression of GDNF, GFRα1 and RET in calvarial osteoblasts
sqRT-PCR analysis revealed that GDNF and its receptors GFRα1 and RET were expressed in the osteoblast cell line MC3T3-E1 ( 
GDNF stimulates MC3T3-E1 cell proliferation
Addition of GDNF to the osteoblast-like cells did not elicit major changes in the number of viable cells over a 2-day culture period in medium supplemented with FBS;
however, at 100 ng/ml GDNF a significant, albeit modest decrease in cell number was evident (82.9% of controls). Conversely, GDNF dose-dependently increased viable MC3T3-E1 numbers in serum-free cultures ( Fig. 2A ).
Biochemical analysis of alkaline phosphate (ALP), a non-specific marker for early osteoblast differentiation (19-20) demonstrated that GDNF had no significant effect on overall ALP activity (data not shown), but following correction for cell numbers a dosedependent decrease in ALP levels at increasing GDNF concentrations in serum-free cultures was evident (Fig. 2B ). These data indicated that the reduced relative ALP activity in GDNF-treated serum-free cultures corresponded with increased cell growth.
To corroborate the WST-1 data, cell proliferation was further analyzed using the BrdUincorporation assay. The BrdU data demonstrated that the mitotic activity in serum-free cultures was greatly reduced compared to the serum-supplemented cultures (Fig. 3 ).
GDNF had a modest, albeit non-significant, effect on BrdU labeling in serumcontaining cultures (23% reduction compared to controls). However, GDNF significantly increased the number of BrdU-labeled cells in serum-free cultures by 103.7% (i.e. two-fold increase) demonstrating that GDNF stimulated cell replication under these conditions (Fig. 3 ).
GDNF does not affect osteoblast cell survival
To further investigate whether GDNF influenced cell survival, the live-dead assay was applied. Results demonstrated that significant cell death occurred in control, serum-free cultures as compared to serum-supplemented cultures (Fig. 4A) . GDNF did not significantly affect the number of dead cells in either serum-containing or serum-free cultures suggesting that GDNF did not affect cell death or survival under either condition (Fig. 4A ).
These data were corroborated by the biochemical cytotoxicity LDH assay demonstrating that GDNF did not influence the level of cell death under serum-free conditions (Fig.   4B ).
Receptor-mediated effects of GDNF
To determine whether GDNF affected the cells through its canonical receptors GFRα1
and RET, cultures were treated with specific compounds known to block GDNF signalling. PI-PLC which hydrolyses the GFRα1 subunits from their glycosylphosphatidylinositol (GPI)-anchored membrane proteins thereby negating GDNF signalling via this receptor, abrogated GDNF effects on viable cell numbers in serum-free cultures (Fig. 5) . These data underline an essential role for GFRα1 in the GDNF effects on osteoblast viability. RPI-1, a competitive ATP-dependent RET kinase inhibitor, dose-dependently blocked GDNF action indicating that activation of the RET co-receptor was necessary to elicit GDNF signalling in these cells (Fig. 5 ).
Interaction of GDNF with TNFα
Finally this study investigated the effects of GDNF in the presence of the proinflammatory cytokine TNF-α, which is known to have profound effects on bone cells including MC3T3-E1 osteoblastic cells (21-23). TNF-α dose-dependently increased viable cell numbers in both serum-containing and serum-free MC3T3-E1 cultures (Fig.   6 ). Addition of GDNF to the cultures supplemented with TNF-α further promoted osteoblastic cell growth in these cultures: The stimulating effects of GDNF appeared relatively modest and non-significant in the 10% FBS cultures (Fig. 6A) ; however, GDNF synergistically increased cell numbers in the presence of TNF-α in serum-free cultures (Fig. 6B) .
Discussion
The current study provides evidence of a direct effect of GDNF on calvarial-derived osteoblasts suggesting a potential role for this neurotrophic factor in the regulation of craniofacial bone metabolism. GDNF as well as both of its canonical receptors GFRα1
and RET were shown to be expressed in MC3T3-E1 osteoblastic cells and signaling through both receptors was needed for GDNF effects on osteoblast cell growth. This is a novel and interesting finding, as previous studies reported that only GDNF and
GFRα1were present in two human osteosarcoma cell lines (Saos-2, MG63) and primary bone marrow stromal cells, but not RET (12) . Thus this latter work had led to the conclusion that GDNF signaling in the bone marrow environment involved interaction with RET-expressing hematopoietic cells (13) (14) . Previous studies have suggested that isolated cells from calvarial bones may behave differently than osteoblasts derived from long bones ((21-23)), which may reflect the mechanistically different processes by which the different structures in the skeleton develop (i.e. flat bones via intramembranous bone formation, whereas long bones through the process of endochondral bone formation; (27) ). Moreover, it is worth noting that a significant part of the craniofacial skeleton originates from neuronal crest -ecto-mesenchymal‖ progenitor cells and therefore the calvarial osteoblasts may therefore exhibit a different molecular repertoire and cell behavior than mesodermal/mesenchymal-derived boneforming cells present in long bones (24-26). RET is considered important for development and differentiation of neural crest-derived tissues, including cranial tissues (28) (29) (30) . GDNF was shown to be co-expressed with GFRα1/2 and RET in dental epithelial and mesenchymal cells during tooth development (31, 32) . Our recent studies indicated that mesenchymal/stromal cell cultures derived from dental pulp also displayed co-expression of GDNF and GFRα1/RET (33) . This study demonstrates that GDNF stimulated MC3T3-E1 cell proliferation in serum-free conditions, which corresponded with a concomitant inhibitory effect on relative ALP activity, a marker of early osteogenic differentiation. Moreover, our data indicate that GDNF at high concentrations exerted a cell growth curbing effect on osteoblasts maintained in serum-supplemented culture medium; an effect that appeared to be associated with a slight increase in ALP activity (Fig. 2) . It is well established that cell differentiation is often inversely related with mitotic activity and our observations indicate that GDNF effect on calvarial osteoblasts mainly involves an action on cellular proliferation with a concomitant inverse effect on immediate differentiation.
Interestingly, GDNF/RET signaling has been shown to be responsible for the antimitotic action in an embryonic neural precursor carcinoma cell line (36) . This effect mediated by p27 kip1 was suggested to be a mechanism by which GDNF regulates cell growth to initiate terminal differentiation (36) . Long-term culture experiments will be required to investigate in further detail the role of GDNF in osteogenic proliferation, differentiation and bone formation.
The mitotic and cell survival actions of GDNF through GFRα1/RET signaling are well documented in the literature underscoring the multifunctional role of GDNF in tissue maintenance, repair and regeneration (1-3). Shi et al (37) described that GDNF promoted mesenchymal stem cell migration and survival; a mechanism by which GDNF may deliver renoprotection and kidney repair. The physiological implications of our findings that GDNF stimulated calvarial osteoblast proliferation under serum-deprived conditions are as yet unclear, but may allude to a novel role of this neurotrophic factor in bone remodeling and repair. GDNF is considered a member of the TGFβ superfamily as it has a partial amino-acid sequence homology and similar structural confirmation to TGF (38) , which comprise growth factors including bone morphogenetic proteins pivotal in regulation of bone development, metabolism and repair. TGF1 can have diverse and multiple effects in different cell systems; notably this signaling molecule has been ascribed a central role in bone cell recruitment, proliferation and differentiation (39) . Interestingly, TGF1 induces translocation of GFR1 to the plasma membrane thereby enabling GDNF signaling through this receptor (40) . It is also worth noting that GDNF is a potent inducer of the nuclear transcription factor, murine GDNF inducible factor (mGIF) which is homologous to the human TGFβ inducible early gene (TIEG) (41) . TIEG expression which has been suggested to play a pivotal role in the regulation of osteoblast differentiation (42) is highly induced in human osteosarcoma cells as well as immortalized human fetal osteoblasts following treatment with TGFβ (43) . It would be fascinating to explore whether GDNF signaling in calvarial osteoblasts is related to induction of TIEG/mGIF.
Considering that GDNF is produced by bone marrow stromal cells as well as osteoblasts (9, 44, 45) , it is tempting to speculate that GDNF in conjunction with other auto-and paracrine factors may be involved in the regulation of osteoblast recruitment in bone growth and remodelling. Indeed, this study demonstrated that GDNF cooperated with the cytokine TNF-α to stimulate osteoblastic cell growth suggesting an interaction between GDNF and TNF-α signalling pathways in osteoblasts. TNF-α has been ascribed a multifunctional role in bone metabolism (22); TNF-α effects may involve a proresorptive (osteoclastic bone degradation) action during inflammatory conditions (21), but TNF-α has also been recognised as an anabolic cytokine stimulating osteogenic migration, proliferation and differentiation (46) (47) (48) (49) (50) . Interestingly, TNF-α has been shown to have neuroprotective capabilities which in part may be dependent on induction of cytoprotective neutrotrophic growth factors such as GDNF (51-53).
Moreover TNF-α was reported to induce GDNF in chondrocytes underscoring a potential role for GDNF in skeletal cells under pro-inflammatory conditions (54).
Further research is warranted to explore the precise role and mechanistic interaction of these pleiotrophic signaling molecules in bone remodeling and their potential therapeutic use in bone regeneration and repair.
In conclusion, this is the first study to report that the neurotrophic factor GDNF is able to influence the proliferation of calvarial osteoblasts via its canonical receptors GFRα/RET expressed on these cells highlighting a novel regulatory pathway in craniofacial bone physiology. Tables and figures   Table 1 (B) Relative LDH levels after 2-days culture in serum-containing or serum-free medium cultures supplemented with 100 ng/ml GDNF (mean ± SD; n = 3). Results are mean ± SD (n = 3-4). . Osteoblastic MC3T3-E1 cell numbers after 2-days' culture in the presence of increasing concentrations of TNF-a with or without 100 ng/ml GDNF in media supplemented with 10% serum (A) or in serum-free cultures (B).Viable cell numbers were assessed using the WST-1 assay; results are expressed as percentage of controls (mean ± SEM; n = 3). ⁄P < 0.05, ⁄⁄⁄P < 0.001 GDNF-supplemented cultures versus corresponding TNF-a controls.
